ArticleJournal for immunotherapy of cancer2026

VSIG4 suppresses antitumor T cell immunity via the SLC3A2-dependent metabolic-ionic checkpoint.

Guoling Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.